Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device
REDWOOD CITY, Calif., Jan 24, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity expands distribution of new Bioheart device on Amazon.com
REDWOOD CITY, Calif., Dec 28, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity completes $12 million non-dilutive debt financing
REDWOOD CITY, Calif., Dec 27, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity, a leader in remote cardiac health monitoring solutions, issues company roadmap in 2021 shareholder letter
REDWOOD CITY, Calif., Dec 07, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company,…
Biotricity delivers Bioheart, a groundbreaking consumer Heart Monitor
REDWOOD CITY, Calif., Nov 10, 2021 (BUSINESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company focused on delivering innovative, remote biometric…
Biotricity releases fiscal 2022 second quarter financial results
REDWOOD CITY, Calif., Nov 04, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced financial results…
Biotricity to report second quarter fiscal 2022 financial results on November 4, 2021
REDWOOD CITY, Calif., Nov 02, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it will…
Biotricity launches Biocare Cardiac application for Samsung’s Galaxy Watch4 series
REDWOOD CITY, Calif., Oct 07, 2021 (ACCESSWIRE) -- Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming…
Remote medical diagnostic company, Biotricity, to ring the Nasdaq stock market opening bell on Thursday, October 7th
REDWOOD CITY, Calif., Oct 06, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced it will be…
Biotricity to discuss expansion of remote monitoring medical device products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
REDWOOD CITY, Calif., Sep 21, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that its Chief…
Biotricity unveils “Biokit” with 3 personal medical devices to expand into cardiac disease management
REDWOOD CITY, Calif., Sep 14, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it has…
Biotricity announces closing of exercise of underwriter’s option to purchase additional common stock
REDWOOD CITY, Calif., Sep 13, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that the…
Biotricity to discuss sales expansion, recent financing, and wearable medical device portfolio expansion at H.C. Wainwright Conference
REDWOOD CITY, Calif., Sep 08, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity completes Nasdaq listing
REDWOOD CITY, Calif., Aug 30, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the closing of…
Biotricity prices $15 million underwritten public offering of common stock and listing on the Nasdaq capital market
REDWOOD CITY, Calif., Aug 26, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of…
Biotricity announces proposed underwritten public offering of common stock in connection with expected Nasdaq listing
REDWOOD CITY, Calif., Aug 25, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends…
Biotricity reports 290% revenue growth year over year in record first quarter
REDWOOD CITY, Calif., Aug 16, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial…
Biotricity to report first quarter Fiscal 2022 financial results on August 16, 2021
REDWOOD CITY, Calif., Aug 12, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will…